Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology)
Hologic announced FDA clearance of a digital cytology system for cervical cancer screening.
Writing in Nature, a group of experts argued that cancers should be reclassified by their molecular characteristics, not the organ of origin.
Using microchip technology to analyze cells in a blood sample, researchers predicted lung cancer response to treatment. (University of Michigan, Cell Reports)
A novel hand-held skin imaging system passed its first clinical test, demonstrating the potential to detect tissue remodeling associated with the development of melanoma. (Orlucent, Pigment Cell & Melanoma Research)
A widely used genomic test to guide chemotherapy decisions in breast cancer may provide less accurate results for Black women. (University of Illinois Chicago, Journal of the National Comprehensive Cancer Network)
An increasing incidence of breast cancer in younger women has accelerated in recent years. (Washington University at St Louis, JAMA Network Open)
Sunday is World Cancer Day, which will continue a 3-year campaign to “Close the Care Gap.”
How cancer uses the nervous system to spread. (Nature)
A new study reaffirms that the worldwide breast cancer burden takes a disproportionate toll on the poorest nations. (NPR)
Persistent inflammatory activity, rather than lack of immune activity, could be the key driver in lung cancer’s acquired resistance to immunotherapy. (Memorial Sloan Kettering Cancer Center, Cancer Cell)
NIH-sponsored research showed that switching to a vegan or keto diet rapidly induces changes in the immune system, which could have implications for use of dietary interventions in several types of disease, including cancer.
-
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow
Please enable JavaScript to view the